相关实验视频

Updated: Feb 26, 2026

A Microscopic 2,3,5-Triphenyltetrazolium Chloride Assay for Accurate and Reliable Analysis of Myocardial Injury

A Microscopic 2,3,5-Triphenyltetrazolium Chloride Assay for Accurate and Reliable Analysis of Myocardial Injury

Published on: November 28, 2025

心肌损伤中的cTnI/cTnT比:一个多队列和实验合成

Tobias Zimmermann¹, Luca Koechlin², Joan Walter³

¹Cardiovascular Research Institute Basel (CRIB) and Department of Cardiology, University Hospital Basel, University of Basel, Basel, Switzerland; Department of Intensive Care Medicine, University Hospital Basel, University of Basel, Basel, Switzerland.

Journal of the American College of Cardiology

|February 25, 2026

概括

心脏素I/T比率有效地将急性心肌损伤与慢性疾病区分开来,挑战了它们的互换性使用. 这个比率有助于区分1型和2型心肌梗塞.

科学领域:

心脏病学心脏病学
生物标志物研究生物标志物研究
诊断医学诊断医学诊断医学

背景情况:

心脏热素 (cTn) I和cTnT是广泛使用的,但通常被认为是互换的.
试点研究表明,cTnI/cTnT比率可能在急性结核和慢性心肌损伤之间有所不同.
这种变异性挑战了目前交换cTnI和cTnT的临床实践.

研究的目的:

挑战cTnI和cTnT在临床实践中的可互换性.
评估cTnI/cTnT比率作为肌心损伤类型和严重性的有意义的生物标志物.
在多个测试,外部数据集和实验模型中验证发现.

主要方法:

分析了来自3项前性研究的9,704名被判定诊断的个人 (未知,慢性或急性心脏病).
测量高灵敏性心脏 I (hs-cTnI) 和hs-cTnT的测量.
回归建模以评估cTnI/cTnT比率与诊断类别的关系及其诊断实用性,内部和外部验证.
在4个模拟不同损伤水平的实验性心肌细胞模型中探索比率.

主要成果:

在急性心脏病 (2.06) 中,cTnI/cTnT比率明显高于慢性心脏病 (0.66) 和没有已知的心脏病 (0.50) 中.
实验模型显示在轻度伤害中cTnT主导释放 (比率~0.5) 和致命伤害中cTnI主导释放 (比率>1).
cTnI/cTnT比率改善了1型和2型急性心肌梗塞之间的区别 (AUC为0.73对0.70).

结论:

cTnI/cTnT比率可以区分急性瘤与慢性/非瘤心肌损伤.
这个比率在临床和实验环境中都具有诊断价值.
这些发现挑战了cTnI和cTnT的可互换性,并改善了AMI分类.

关键词:

心脏中的托罗邦尼 (troponin)不同释放的差异释放.实验模型是一个实验模型.病理生理学病理生理学这是一个比率比率的比率.

更多相关视频

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs

Published on: April 17, 2021

Improvement of a Closed Chest Porcine Myocardial Infarction Model by Standardization of Tissue and Blood Sampling Procedures

Improvement of a Closed Chest Porcine Myocardial Infarction Model by Standardization of Tissue and Blood Sampling Procedures

Published on: March 12, 2018

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...

Acute Coronary Syndrome III: Diagnostic Studies

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...